SUNCIST: A Study of Calmangafodipir in Healthy Japanese and Caucasian Subjects
Clinical trial NCT03430999 · COMPLETED
Trial details
- NCT number
- NCT03430999
- Sponsor
- Egetis Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-07
- Primary completion
- 2017-12-18
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.